hellotayssir/FinQA_TAT-QA_financial_finetuning_dataset huggingface dataset:
N. NET INCOME PER COMMON SHARE
The following table sets forth the computation of basic and diluted net income per common share:
(1) Incremental shares from the assumed conversion of the convertible notes was calculated using the difference between the average Teradyne stock price for the period and the conversion price of $31.62, multiplied by 14.5 million shares. The result of this calculation, representing the total intrinsic value of the convertible debt, was divided by the average Teradyne stock price for the period.
(2) Convertible notes hedge warrant shares were calculated using the difference between the average Teradyne stock price for the period and the warrant price of $39.68, multiplied by 14.5 million shares. The result of this calculation, representing the total intrinsic value of the warrant, was divided by the average Teradyne stock price for the period.
The computation of diluted net income per common share for 2018 excludes the effect of the potential exercise of stock options to purchase approximately 0.1 million shares and restricted stock units to purchase approximately 0.5 million shares because the effect would have been anti-dilutive.
The computation of diluted net income per common share for 2017 excludes the effect of the potential exercise of stock options to purchase approximately 0.1 million shares because the effect would have been antidilutive.
Table:
 | 2019 | 2018 | 2017
 |  | (in thousands, except per share amounts) | 
Net income for basic and diluted net income per share | $467,468 | $451,779 | $257,692
Weighted average common shares-basic | 170,425 | 187,672 | 198,069
Effect of dilutive potential common shares: |  |  | 
Incremental shares from assumed conversion of convertible notes (1) | 4,909 | 2,749 | 1,298
Convertible note hedge warrant shares (2) | 2,698 | 485 | 112
Restricted stock units | 1,236 | 1,385 | 1,800
Stock options | 178 | 278 | 335
Employee stock purchase rights | 13 | 36 | 27
Dilutive potential common shares | 9,034 | 4,933 | 3,572
Weighted average common shares-diluted | 179,459 | 192,605 | 201,641
Net income per common share-basic | $2.74 | $2.41 | $1.30
Net income per common share-diluted | $2.60 | $2.35 | $1.28


Question: In which years was the net income pre common share calculated?
Answer: 2019, 2018, 2017
Under Article 35 of our Articles of Association, our financial year extends from January 1 to December 31, which is the period end of each fiscal year. In 2019, the first quarter ended on March 30, the second quarter ended on June 29, the third quarter ended on September 28 and the fourth quarter ended on December 31.
In 2020, the first quarter will end on March 28, the second quarter will end on June 27, the third quarter will end on September 26 and the fourth quarter will end on December 31.
Based on our fiscal calendar, the distribution of our revenues and expenses by quarter may be unbalanced due to a different number of days in the various quarters of the fiscal year and can also differ from equivalent prior years’ periods, as illustrated in the below table for the years 2018, 2019 and 2020.
Table:
 | Q1 | Q2 | Q3 | Q4
 | Days | Days | Days | Days
2018 | 90 | 91 | 91 | 93
2019 | 89 | 91 | 91 | 94
2020 | 88 | 91 | 91 | 96


Question: What is the annual calendar of the financial cycle?
Answer: from January 1 to December 31
Fiscal 2018 Restructuring Plan
During Fiscal 2018 and in the context of our acquisitions of Covisint, Guidance and Hightail (each defined below), we began to implement restructuring activities to streamline our operations (collectively referred to as the Fiscal 2018 Restructuring Plan). The Fiscal 2018 Restructuring Plan charges relate to workforce reductions and facility consolidations. These charges require management to make certain judgments and estimates regarding the amount and timing of restructuring charges or recoveries. Our estimated liability could change subsequent to its recognition, requiring adjustments to the expense and the liability recorded. On a quarterly basis, we conduct an evaluation of the related liabilities and expenses and revise our assumptions and estimates as appropriate.
Since the inception of the plan, approximately $10.7 million has been recorded within "Special charges (recoveries)" to date. We do not expect to incur any further significant charges relating to this plan.
A reconciliation of the beginning and ending liability for the year ended June 30, 2019 and 2018 is shown below.
Table:
Fiscal 2018 Restructuring Plan | Workforce reduction | Facility costs | Total
Balance payable as at June 30, 2017 | $— | $— | $—
Accruals and adjustments | 8,511 | 1,643 | 10,154
Cash payments | (8,845) | (489) | (9,334)
Foreign exchange and other non-cash adjustments | 892 | 11 | 903
Balance payable as at June 30, 2018 | $558 | $1,165 | $1,723
Accruals and adjustments | (20) | 535 | 515
Cash payments | (337) | (928) | (1,265)
Foreign exchange and other non-cash adjustments | (51) | (286) | (337)
Balance payable as at June 30, 2019 | $150 | $486 | $636


Question: For Balance payable as at June 30, 2019, What is the difference between Workforce reduction and Facility costs?
Answer: -336
Calculation: 150-486
hologic , inc . notes to consolidated financial statements 2014 ( continued ) ( in thousands , except per share data ) future minimum lease payments under all the company 2019s operating leases are approximately as follows: .

Table:
fiscal years ending | amount
september 24 2005 | $ 4848
september 30 2006 | 4672
september 29 2007 | 3680
september 27 2008 | 3237
september 26 2009 | 3158
thereafter | 40764
total ( not reduced by minimum sublease rentals of $ 165 ) | $ 60359
the company subleases a portion of its bedford facility and has received rental income of $ 277 , $ 410 and $ 682 for fiscal years 2004 , 2003 and 2002 , respectively , which has been recorded as an offset to rent expense in the accompanying statements of income .
rental expense , net of sublease income , was approximately $ 4660 , $ 4963 , and $ 2462 for fiscal 2004 , 2003 and 2002 , respectively .
9 .
business segments and geographic information the company reports segment information in accordance with sfas no .
131 , disclosures about segments of an enterprise and related information .
operating segments are identified as components of an enterprise about which separate , discrete financial information is available for evaluation by the chief operating decision maker , or decision-making group , in making decisions how to allocate resources and assess performance .
the company 2019s chief decision-maker , as defined under sfas no .
131 , is the chief executive officer .
to date , the company has viewed its operations and manages its business as four principal operating segments : the manufacture and sale of mammography products , osteoporosis assessment products , digital detectors and other products .
as a result of the company 2019s implementation of a company wide integrated software application in fiscal 2003 , identifiable assets for the four principal operating segments only consist of inventories , intangible assets , and property and equipment .
the company has presented all other assets as corporate assets .
prior periods have been restated to conform to this presentation .
intersegment sales and transfers are not significant. .

Question: what was the percentage change in rental expense between 2003 and 2004?
Answer: -6%
Calculation: subtract(4660, 4963), divide(#0, 4963)
Total Shareholder Return Awards
During the years ended December 31, 2019, 2018, and 2017, pursuant to the 2016 Incentive Plan, the Company granted total shareholder return awards (“TSRs”). TSRs are performance shares that are earned, if at all, based upon the Company’s total shareholder return as compared to a group of peer companies over a three-year performance period. The award payout can range from 0% to 200%. To determine the grant date fair value of the TSRs, a Monte Carlo simulation model is used. The Company recognizes compensation expense for the TSRs over a three-year performance period based on the grant date fair value.
The grant date fair value of the TSRs was estimated using the following weighted-average assumptions:
Table:
 |  | Years Ended December 31, | 
 | 2019 | 2018 | 2017
Expected life (years) | 2.8 | 2.9 | 2.9
Interest rate | 2.5% | 2.4% | 1.5%
Volatility | 29.3% | 28.0% | 26.5%
Expected dividend yield | — | — | —


Question: What was the percentage change in expected life (years) between 2018 and 2019?
Answer: -3.45
Calculation: (2.8-2.9)/2.9
The activity for unrecognized gross tax benefits is as follows (in millions):
Included in the December 31, 2019 balance of $130.0 million is $97.2 million related to unrecognized tax benefits that, if recognized, would impact the annual effective tax rate. Also included in the balance of unrecognized tax benefits as of December 31, 2019 is $32.8 million of benefit that, if recognized, would result in adjustments to other tax accounts, primarily deferred taxes.
Although the Company cannot predict the timing of resolution with taxing authorities, if any, the Company believes it is reasonably possible that its unrecognized tax benefits will be reduced by $1.5 million in the next 12 months due to settlement with tax authorities or expiration of the applicable statute of limitations. The Company did not recognize any additional tax benefit or expense for interest and penalties during the year ended December 31, 2019.
The Company recognized approximately $0.8 million of tax benefit and $1.5 million of tax expense for interest and penalties during the years ended December 31, 2018 and 2017, respectively. The Company had approximately $5.1 million, $5.1 million, and $5.9 million of accrued interest and penalties at December 31, 2019, 2018, and 2017, respectively. The Company recognizes interest and penalties accrued in relation to unrecognized tax benefits in tax expense.
Tax years prior to 2016 are generally not subject to examination by the IRS except for items involving tax attributes that have been carried forward to tax years whose statute of limitations remains open. The Company is not currently under IRS examination. For state returns, the Company is generally not subject to income tax examinations for years prior to 2015.
The Company is also subject to routine examinations by various foreign tax jurisdictions in which it operates. With respect to jurisdictions outside the United States, the Company's subsidiaries are generally no longer subject to income tax audits for years prior to 2009. The Company is currently under audit in the following jurisdictions including, but not limited to, Canada, China, the Czech Republic, the Philippines, Singapore and the United Kingdom.
Table:
 | 2019 | 2018 | 2017
Balance at beginning of year | $112.2 | $114.8 | $136.7
Acquired balances | 15.5 | — | —
Additions for tax benefits related to the current year | 9.4 | 7.4 | 23.6
Additions for tax benefits of prior years | 8.0 | 2.8 | 4.7
Reductions for tax benefits of prior years | (0.2) | (1.9) | (1.6)
Lapse of statute | (8.2) | (10.9) | (16.3)
Settlements | (6.7) | — | (4.9)
Change in rate due to U.S. Tax Reform | — | — | (27.4)
Balance at end of year | $130.0 | $112.2 | $114.8


Question: How much was accrued interest and penalties at December 31, 2018?
Answer: $5.1 million
The following is a summary of investments, including those that meet the definition of a cash equivalent, as of December 31, 2018 (in thousands):
As of December 31, 2019, the Company’s investment in corporate bonds and US treasury securities had a weighted-average maturity date of approximately five months. Unrealized gains and losses on investments were not significant individually or in aggregate, and the Company does not believe the unrealized losses represent other-than-temporary impairments as of December 31, 2019.
Table:
 | Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value
Current assets: |  |  |  | 
Cash | $54,275 | $— | $— | $54,275
Cash equivalents: |  |  |  | 
Money market funds | 129,321 | — | — | 129,321
Total cash equivalents | 129,321 | — | — | 129,321
Total cash and cash equivalents | 183,596 | — | — | 183,596
Short-term investments: |  |  |  | 
Corporate bonds | 58,115 | — | (82) | 58,033
US treasury securities | 138,826 | — | (100) | 138,726
Commercial paper | 7,973 | — | — | 7,973
Total short-term investments | 204,914 | — | (182) | 204,732
Long-term investments: |  |  |  | 
Strategic investments | 1,250 | — | — | 1,250
Total long-term investments | $1,250 | $— | $— | $1,250


Question: What was the sum of amortized cost of corporate bonds and US treasury securities?
Answer: 196941
Calculation: 58,115+138,826
Semiconductor and IP Licensing Segment
(1) Excludes operating expenses which are not allocated on a segment basis.
Semiconductor and IP Licensing segment revenue for the year ended December 31, 2019 was $81.9 million as compared to $186.4 million for the year ended December 31, 2018, a decrease of $104.5 million. The decrease in revenue was due principally to revenue recorded in 2018 related to the Samsung settlement and license agreement executed in December 2018, partially offset by a one-time payment from a new license agreement signed in December 2019.
Table:
 |  | Years Ended December 31, | 
 | 2019 | 2018 | 2017
 |  | (in thousands) | 
Revenue: |  |  | 
Royalty and license fees | $81,943 | $186,425 | $205,809
Total revenue | 81,943 | 186,425 | 205,809
Operating expenses: |  |  | 
Research, development and other related costs | 28,732 | 27,514 | 30,039
Litigation | 3,471 | 26,099 | 36,209
Amortization | 11,871 | 19,906 | 21,590
Total operating expenses (1) | 44,074 | 73,519 | 87,838
Total operating income | $37,869 | $112,906 | $117,971


Question: What was the revenue change between 2018 and 2019?
Answer: $104.5 million
18. Revenue
Effective September 1, 2018, the Company adopted ASU 2014-09, Revenue Recognition (Topic 606). The new standard is a comprehensive new revenue recognition model that requires the Company to recognize revenue in a manner which depicts the transfer of goods or services to its customers at an amount that reflects the consideration the Company expects to receive in exchange for those goods or services.
Prior to the adoption of the new standard, the Company recognized substantially all of its revenue from contracts with customers at a point in time, which was generally when the goods were shipped to or received by the customer, title and risk of ownership had passed, the price to the buyer was fixed or determinable and collectability was reasonably assured (net of estimated returns). Under the new standard, the Company recognizes revenue over time for the majority of its contracts with customers which results in revenue for those customers being recognized earlier than under the previous guidance. Revenue for all other contracts with customers continues to be recognized at a point in time, similar to recognition prior to the adoption of the standard.
Additionally, the new standard impacts the Company’s accounting for certain fulfillment costs, which include upfront costs to prepare for manufacturing activities that are expected to be recovered. Under the new standard, such upfront costs are recognized as an asset and amortized on a systematic basis consistent with the pattern of the transfer of control of the products or services to which to the asset relates.
The following table presents the effect of the adoption of the new revenue guidance on the Consolidated Balance Sheets as of August 31, 2019 (in thousands):
(1) Differences primarily relate to the timing of revenue recognition for over time customers and certain balance sheet reclassifications.
(2) Differences primarily relate to the timing of recognition and recovery of fulfillment costs and certain balance sheet reclassifications.
(3) Included within accrued expenses on the Consolidated Balance Sheets.
(4) Differences included in contract liabilities as of September 1, 2018.
Table:
 | August 31, 2019 | 
 | As reported | Balance without the adoption of ASU 2014-09
Assets |  | 
Contract assets (1) | $911,940 | $—
Inventories, net (1) | $3,023,003 | $3,761,591
Prepaid expenses and other current assets(1)(2) | $501,573 | $514,769
Deferred income taxes(1) | $198,827 | $202,791
Liabilities |  | 
Contract liabilities(2)(3) | $511,329 | $—
Deferred income(2)(3)(4) | $— | $521,035
Other accrued expenses(3)(4) | $1,877,908 | $1,868,201
Deferred income taxes(1) | $115,818 | $111,304
Equity |  | 
Retained earnings(1)(2) | $2,037,037 | $1,885,360


Question: What was the change in Inventories, net due to adoption of ASU 2014-09?
Answer: -738588
Calculation: 3,023,003-3,761,591
INCOME TAX EXPENSE
Below is a summary of the difference between income tax expense computed by applying the statutory income tax rate to income before income tax expense and the actual income tax expense for the year.
Our effective income tax rate this year was 25.8% compared to 26.9% for 2018. The effective income tax rate for 2019 was lower than the statutory tax rate primarily as a result of a reduction to the Alberta corporate income tax rate over a four-year period.
Table:
(In millions of dollars, except tax rates) | Years ended December 31 |  | 
 | 2019 | 2018 | %Chg
Adjusted EBITDA 1 | 6,212 | 5,983 | 4
Deduct (add): |  |  | 
Depreciation and amortization | 2,488 | 2,211 | 13
Gain on disposition of property, plant and equipment | - | (16) | (100)
Restructuring, acquisition and other | 139 | 210 | (34)
Finance costs | 840 | 793 | 6
Other income | (10) | (32) | (69)
Income tax expense | 712 | 758 | (6)
Net income | 2,043 | 2,059 | (1)


Question: What caused the decrease in effective tax rate from 2018 to 2019?
Answer: reduction to the Alberta corporate income tax rate over a four-year period
8. Stocks
Note
1. Finished goods in 2018 includes £2.2 million relating to deferred costs which has been reclassified from prepayments; see note 1 for further details.
There were no stock write-downs recognised in the period (2018 nil) and there were no reversals of prior period stock write-downs (2018 nil).
No stock is carried at fair value less costs to sell (2018 nil).
Table:
 | 2019 | 2018
 | £ million | £ million
Work in progress | 0.7 | 0.6
Finished goods¹ | 3.2 | 3.9
 | 3.9 | 4.5


Question: Was there any stock write-downs recognised in the period?
Answer: There were no stock write-downs recognised in the period
Stock-Based Compensation
The Company recognized total stock-based compensation cost related to equity incentive awards as follows (in thousands):
A small portion of stock-based compensation cost above is capitalized in accordance with the accounting guidance for internal-use software. The Company uses the straight-line attribution method for recognizing stock-based compensation expense.
Table:
 |  | For the Year Ended December 31, | 
 | 2019 | 2018 | 2017
Stock-based compensation cost: |  |  | 
Common stock warrants | $— | $512 | $484
Stock options | 16,489 | 13,279 | 11,295
Restricted stock units | 14,585 | 90 | —
Employee stock purchase plan | 3,326 | 2,069 | —
Total stock-based compensation cost | $34,400 | $15,950 | $11,779


Question: What are the company's respective restricted stock units between 2017 to 2019?
Answer: 0, 90, 14,585
16. Segment, Geographic, and Significant Customer Information
With the exception of property and equipment, we do not identify or allocate our long-lived assets by geographic area. The following table presents property and equipment information for geographic areas based on the physical location of the assets (in millions):
Table:
 | April 26, 2019 | April 27, 2018
U.S. | $ 572 | $ 566
International | 187 | 190
Total | $ 759 | $ 756


Question: What was the change in U.S. property and equipment between 2018 and 2019?
Answer: 6
Calculation: 572-566
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
ADTRAN’s common stock is traded on the NASDAQ Global Select Market under the symbol ADTN. As of February 19, 2020, ADTRAN had 163 stockholders of record and approximately 6,972 beneficial owners of shares held in street name. The following table shows the high and low closing prices per share for our common stock as reported by NASDAQ for the periods indicated.
Table:
COMMON STOCK PRICES |  |  |  | 
2019 | First Quarter | Second Quarter | Third Quarter | Fourth Quarter
High | $15.40 | $17.81 | $16.40 | $11.59
Low | $10.49 | $13.76 | $ 9.92 | $ 8.09


Question: What was the average low closing price for 2019?
Answer: 10.57
Calculation: ( $10.49 + $13.76 + $ 9.92 + $ 8.09 )/4
The following table provides a reconciliation of Adjusted Gross Profit to Gross Profit, the most directly comparable financial measure presented in accordance with U.S. GAAP:
(a) Represents depreciation and amortization expense included in cost of goods sold
(b) Represents additional operating costs incurred in connection with the start-up of our new manufacturing lines as part of the Freshpet Kitchens expansion project in 2016 that included adding two additional product lines.
(c) Represents non-cash share-based compensation expense included in cost of goods sold.
Table:
 | Twelve Months Ended December 31, |  |  |  | 
 | 2019 | 2018 | 2017 | 2016 | 2015
 | (Dollars in thousands) |  |  |  | 
Gross Profit | $114,197 | $89,990 | $72,416 | $60,371 | $54,649
Depreciation expense (a) | 6,370 | 6,089 | 5,791 | 4,028 | 2,566
Plant start-up expense (b) | — | — | — | 1,628 | —
Non-cash share-based compensation (c) | 922 | 859 | 243 | 221 | 201
Adjusted Gross Profit | $121,489 | $96,938 | $78,450 | $66,248 | $57,416
Adjusted Gross Profit as a % of Net Sales | 49.4% | 50.2% | 51.5% | 51.1% | 50.6%


Question: What are the 3 expenses shown in the table?
Answer: Depreciation expense, Plant start-up expense, Non-cash share-based compensation expense
The Company’s contractual obligations as of December 31, 2019, consist of our obligations as borrower under our 2019 Senior Secured Credit Facility, our obligations related to financing of our three 2018 Newbuildings.
The following table sets out financial, commercial and other obligations outstanding as of December 31, 2019.
Notes:
(1) Refers to obligation to repay indebtedness outstanding as of December 31, 2019.
(2) Refers to estimated interest payments over the term of the indebtedness outstanding as of December 31, 2019. Estimate based on applicable interest rate and drawn amount as of December 31, 2019.
(3) Refers to obligation to repay indebtedness outstanding as of December 31, 2019 for three 2018 Newbuildings.
(4) Refers to estimated interest payments over the term of the indebtedness outstanding as of December 31, 2019. Estimate based on applicable interest as of December 31, 2019 for the financing of the three 2018 Newbuildings.
(5) Refers to the future obligation as of December 31, 2019 to pay for operating lease liabilities at nominal values.
*The new five-year senior secured credit facility for $306.1 million is amortizing with a twenty-year maturity profile, carries a floating LIBOR interest rate plus a margin and matures in February 2024. Further, the agreement contains a discretionary excess cash amortization mechanism for the lender that equals 50% of the net earnings from the collateral vessels, less capex provision and fixed amortization.
Table:
Contractual Obligations in $’000s  | Total   | Less than 1 year   | 1-3 years   | 3-5 years   | More than 5 years
Senior Secured Credit Facility (1)* | 291,798 | 18,749 | 30,610 | 242,439 | -
Interest Payments (2) | 82,255 | 21,690 | 39,624 | 20,941 | -
Financing of 2018 Newbuildings (3) | 119,867 | 7,630 | 16,287 | 17,849 | 78,101
Interest Payments 2018 Newbuildings (4) | 47,517 | 7,674 | 13,739 | 11,526 | 14,578
Operating Lease Liabilities (5)   | 1,937 | 500 | 638 | 587 | 212
Total   | 543,374 | 56,243 | 100,898 | 293,342 | 92,891


Question: What is the average total Senior Secured Credit Facility and Interest Payments?
Answer: 187026.5
Calculation: (291,798 + 82,255)/2